Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Gilead Sciences, Inc.
Scientific Title
A Phase 2 Open-Label Study of Sacituzumab Govitecan (IMMU-132) in Subjects With Metastatic Solid Tumors